4.1 Article

ATP as a cotransmitter in sympathetic and parasympathetic nerves-another Burnstock legacy

期刊

出版社

ELSEVIER
DOI: 10.1016/j.autneu.2021.102860

关键词

ATP; Cotransmission; Sympathetic; Parasympathetic; Vas deferens; Urinary bladder; Nucleotidase

资金

  1. Wellcome Trust
  2. Astra plc
  3. Carnegie Trust
  4. Scottish Hospitals Endowment Research Trust
  5. Tenovus Scotland

向作者/读者索取更多资源

Geoff Burnstock's scientific legacy includes the identification of ATP as a neurotransmitter in the gut, the discovery of a large family of receptors, and the demonstration of ATP's role as an excitatory cotransmitter in autonomic nerves. The potential therapeutic application of cotransmission in treating dysfunctional bladder disorders is a promising area of research.
Geoff Burnstock created an outstanding scientific legacy that includes identification of adenosine 5 '-triphosphate (ATP) as an inhibitory neurotransmitter in the gut, the discovery and characterisation of a large family of purine and uridine nucleotide-sensitive ionotropic P2X and metabotropic P2Y receptors and the demonstration that ATP is as an excitatory cotransmitter in autonomic nerves. The evidence for cotransmission includes that: 1) ATP is costored with noradrenaline in synaptic vesicles in postganglionic sympathetic nerves innervating smooth muscle tissues, including the vas deferens and most arteries. 2) When coreleased with noradrenaline, ATP acts at postjunctional P2X1 receptors to elicit depolarisation, Ca2+ influx, Ca2+ sensitisation and contraction. 3) ATP is also coreleased with acetylcholine from postganglionic parasympathetic nerves innervating the urinary bladder, where it stimulates postjunctional P2X1 receptors, and a second, as yet unidentified site to evoke contraction of detrusor smooth muscle. In both systems membrane-bound ecto-enzymes and soluble nucleotidases released from postganglionic nerves dephosphorylate ATP and so terminate its neurotransmitter actions. Currently, the most promising potential area of therapeutic application relating to cotransmission is treatment of dysfunctional urinary bladder. This family of disorders is associated with the appearance of a purinergic component of neurogenic contractions. This component is an attractive target for drug development and targeting it may be a rewarding area of research.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.1
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据